Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Pfizer and BioNTech collaborate on mRNA-based vaccine to prevent shingles

Jan. 7, 2022

Tonix and Kansas State enter option agreement and research collaboration on LNP-free mRNA vaccines

Jan. 5, 2022

NaNotics and Mayo Clinic collaborate on NaNot targeting soluble PD-L1

Jan. 5, 2022

Biogen exercises option to license preclinical ASO for spinal muscular atrophy

Jan. 5, 2022

Kyverna licenses CAR T construct for use in autologous and allogeneic therapies

Jan. 4, 2022

Ovid licenses KCC2 transporter activators from AstraZeneca

Jan. 4, 2022

WuXi Biologics and ImmuneOncia to jointly develop PD-L1/CD47 bispecific antibody

Dec. 28, 2021

BiondVax signs agreements with Max Planck and UMG for COVID-19 NanoAbs

Dec. 23, 2021

RaQualia and Hisamitsu to enter license agreement for sodium channel blocker

Dec. 21, 2021

FibroGen exercises license option for HiFiBiO's anti-CCR8 monoclonal antibody program

Dec. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...